pemvidutide vs semaglutide New study comparing to weight loss drugs. Although one beat out the other Upcoming GLP-1 RAs for NASH:

Oral medications follow their own titration principles

M1 macrophages also release a large amount of pro-inflammatory factors, such as TNF-, IL-1 and other pro-inflammatory factors, which can cause peripheral and central sensitization, and then enhance the esophaguss susceptibility to a variety of reflux stimuli

The beneficial effects of estrogens and GLP-1 agonists observed in other metabolic diseases raise the possibility that their combined use could also prevent or delay the onset of Alzheimers disease

Common side effects: AOD 9604 has essentially none (indistinguishable from placebo)

Searches were performed in PubMed and Google Scholar using MeSH terms and related keywords, combined with Boolean operators, to locate studies assessing incretin-based therapies in neurodegenerative conditions